Locations:
Search IconSearch

Research

18-NEU-736-Friedman-Pediatric-Stroke-650×450
April 20, 2018/Neurosciences/Research

VIPS II Study Homes In on Pediatric Arterial Ischemic Stroke

A key focus is characterizing arteriopathy, a prime predictor of recurrence

18-NEU-810-Stroke-Rehab-Katzan-650×450 (003)
April 13, 2018/Geriatrics

Post-Stroke Health Impacts Merit New Emphases in Stroke Survivor Care

Executive function, social roles and physical function loom large in new study

18-NEU-678-Progressive MS-650×450
March 23, 2018/Neurosciences/Research

Disability Progression Slowed for First Time in Large Trial of Secondary Progressive MS

Phase 3 EXPAND trial suggests potential utility of siponimod

18-NEU-505-Fernandez-Parkinson-Spark
March 12, 2018/Neurosciences/Research

Disease-Modifying Parkinson Therapy Is Put to the Test in Phase 2 Trial

Novel monoclonal antibody takes aim at alpha-synuclein clusters

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-NEU-618-Vogelbaum-Brain-Tumor-650×450
March 1, 2018/Cancer

In Brain Tumor Therapeutics, Options for Bypassing the Blood-Brain Barrier Are Burgeoning

Cleveland Clinic offers an abundance of direct delivery trials

18-NEU-687 Yan-650×450

Reversal of Alzheimer’s in Mouse Model Boosts BACE1 Inhibitors’ Prospects in Humans

Most substantial reversal of amyloid deposition in an animal study to date

18-NEU-549-Mobile-Stroke-Video-3-650×450
January 26, 2018/Neurosciences/Research

Experience Brings Heightened Efficiency to Mobile Stroke Unit, Study Shows (Video)

Door-to-needle time improved by 26 percent from 2014 to 2017

18-NEU-548 650×450
January 25, 2018/Neurosciences/Research

Benefits of Ultra-Early IV tPA Extend to Emergent Large Vessel Occlusions Too (Video)

First study of this question supports prioritizing speed in ELVO cases

Streamlined STEMI Protocol Slashes Door-to-Balloon Times
January 25, 2018/Neurosciences/Research

Comprehensive Vs. Primary Stroke Centers: Is There a Quality Difference?

CSCs achieve timelier acute reperfusion therapy, national study finds

17-NEU-4426-Uchino-Defuse3-Trial-650×450
January 24, 2018/Neurosciences/Research

Thrombectomy 6 to 16 Hours After Stroke Onset Still Yields Threefold Rise in Functional Recovery

DEFUSE 3 results support lengthening treatment window in imaging-selected patients

BackPage 13 of 21Next

Advertisement

Ad